Vanguard Capital Management
USNA icon

Vanguard Capital Management’s Usana Health Sciences USNA Stock Holding History

Vanguard Capital Management’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.4M Buy
487,370
+8,327
+2% +$157K ﹤0.01% 2790
2026
Q1 		$8.37M Buy
+479,043
New +$9.51M ﹤0.01% 2832

Other funds holding USNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3B AUM 119.43% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Capital Management's USNA Position: Q2 2026 in Review

Vanguard Capital Management increased its Usana Health Sciences (USNA) stake by 1.7% in Q2 2026, buying an estimated $157K and bringing the position to 487,370 shares worth $10.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2790.

Vanguard Capital Management first reported a position in USNA in Q1 2026 and has held it in 2 quarters since. 137 funds tracked by Wall St. Rank hold USNA as of Q2 2026.

  • Vanguard Capital Management held 487,370 shares of Usana Health Sciences worth $10.4M as of Q2 2026.
  • Vanguard Capital Management bought 8,327 Usana Health Sciences shares in Q2 2026, an estimated $157K.
  • Usana Health Sciences made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #2790 holding.
  • Vanguard Capital Management first reported a position in Usana Health Sciences in Q1 2026 and has held it in 2 quarters since.
  • 137 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.